Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06211829 · ClinicalTrials.gov registry record
An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 77
- Enrollment target
NCT06211829 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 77 participants.
The verdict
NCT06211829 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
In July 2020, a bundle (Appendix C) was implemented at Methodist Dallas Medical Center where all patients with SAB were reviewed by the antimicrobial stewardship pharmacist (Monday - Friday from 0700 to 1500), a note outlining optimal interventions was written in the electronic medical record (EMR), and the recommendations were communicated to the primary team via secure messaging or telephone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2025-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06211829
The ClinicalTrials.gov registry entry for NCT06211829 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06211829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06211829 about?
NCT06211829 is a clinical study titled "An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections". In July 2020, a bundle (Appendix C) was implemented at Methodist Dallas Medical Center where all patients with SAB were reviewed by the antimicrobial stewardship pharmacist (Monday - Friday from 0700 to 1500), a note outlining optimal interventions was written in the electronic medical record (EMR),...
What is the current status of trial NCT06211829?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2022-05-18. Estimated completion is 2025-07-14.
Who is sponsoring clinical trial NCT06211829?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.